156 related articles for article (PubMed ID: 3495600)
1. Generation of NK cell activity from human bone marrow.
Lotzová E; Savary CA
J Immunol; 1987 Jul; 139(1):279-84. PubMed ID: 3495600
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
4. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.
Kalland T
J Immunol; 1986 Oct; 137(7):2268-71. PubMed ID: 2876040
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
7. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
Tilden AB; Itoh K; Balch CM
J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
Damle NK; Doyle LV; Bradley EC
J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
[TBL] [Abstract][Full Text] [Related]
9. Characterization of natural killer cells cultured from human bone marrow cells.
Yoda Y; Kawakami Z; Shibuya A; Abe T
Exp Hematol; 1988 Sep; 16(8):712-7. PubMed ID: 3042444
[TBL] [Abstract][Full Text] [Related]
10. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
Lotzová E; Savary CA
Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
[TBL] [Abstract][Full Text] [Related]
11. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
Lotzová E; Savary CA; Herberman RB
J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
Abo T; Cooper MD; Balch CM
J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
[TBL] [Abstract][Full Text] [Related]
13. Long-term cultures of mouse bone marrow cells: a model for studying the generation of natural killer cells.
Ayroldi E; Cannarile L; D'Adamio F; Delfino D; Migliorati G; Riccardi C
Nat Immun; 1992; 11(6):317-27. PubMed ID: 1477494
[TBL] [Abstract][Full Text] [Related]
14. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
Migliorati G; Cannarile L; Herberman RB; Bartocci A; Stanley ER; Riccardi C
J Immunol; 1987 Jun; 138(11):3618-25. PubMed ID: 2884255
[TBL] [Abstract][Full Text] [Related]
16. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.
Tarkkanen J; Saksela E; Lanier LL
J Immunol; 1986 Oct; 137(8):2428-33. PubMed ID: 3093576
[TBL] [Abstract][Full Text] [Related]
17. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
[TBL] [Abstract][Full Text] [Related]
18. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
19. Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.
Lotzová E; Savary CA; Champlin RE
J Immunol; 1993 Jun; 150(12):5263-9. PubMed ID: 7685792
[TBL] [Abstract][Full Text] [Related]
20. Common precursor pool marker for allospecific (CTL) and nonspecific (NK and activated) cytotoxic cells in the bone marrow.
Nieminen P; Saksela E
J Immunol; 1985 Feb; 134(2):699-703. PubMed ID: 3155539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
